Genome-wide association studies and the clinic: a focus on breast cancerFrom pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resourceBeyond CA125: the coming of age of ovarian cancer biomarkersIonotropic GABA receptor antagonism-induced adverse outcome pathways for potential neurotoxicity biomarkersCirculating mitochondrial biomarkers for drug-induced liver injuryPredictive biomarkers for treatment selection: statistical considerationsBiomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory scienceMolecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHTranslating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validationmicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentTranscriptomics: a sword to cut the Gordian knot of traditional Chinese medicineDefining glycoprotein cancer biomarkers by MS in conjunction with glycoprotein enrichmentDevelopment of biomarkers to optimize pediatric patient management: what makes children different?γ-band abnormalities as markers of autism spectrum disordersThe search for circulating epilepsy biomarkersCan knowledge of germline markers of toxicity optimize dosing and efficacy of cancer therapy?Personalized medicine: applying 'omics' to lung fibrosisTranslational metabolomics in cancer researchGuanylyl cyclase C as a biomarker in colorectal cancerEarly diagnosis of pancreatic cancer: challenges and new developmentsEvaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityCirculating microRNAs: potential biomarkers for common malignanciesValue of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisBiomarkers for CNS involvement in pediatric lupusGain-of-function mutations in potassium channel subunit KCNE2 associated with early-onset lone atrial fibrillationLipoprotein(a) should be taken much more seriouslyLung cancer epigenetics: emerging biomarkersMass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimensIntracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomaliesUsing biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnessesUrinary biomarkers as a diagnostic tool for acute kidney injury.Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.Biomarker identification from next-generation sequencing data for pathogen bacteria characterization and surveillance.Identifying network-based biomarkers of complex diseases from high-throughput data.Biomarkers of multiorgan injury in neonatal encephalopathy.Biomarkers for fatal immune response to stem cell treatment could reduce mortality.Searching for potential biomarkers that can be used as biomarkers for diagnosing ankylosing spondylitis.High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.From the bench to the clinic and back again: translational biomarker discovery using in silico mining of pharmacogenomic data.Mass spectrometry MALDI imaging of colon cancer biomarkers: a new diagnostic paradigm.
P1433
Q22064616-19D195C8-E0C1-4F26-8C86-3734EBF9694BQ24632079-ADB96D1D-54D3-4CE2-949C-DEA01CAAF355Q24651567-498D2DDF-FA41-484A-AC08-15E9E7715B82Q26778336-6F05C64E-2559-48BF-A59C-E429C9C01B13Q26778353-C61ED3A4-8AB4-4328-9C20-5E3A3C59B700Q26778367-B07ACA9A-D200-41E5-8296-2729EF87A5B7Q26778374-5BF7883A-D8F3-4CAF-AE10-3D5FAB67E9B5Q26778376-57EA3A35-BC00-4CFA-B86C-FDB165B47498Q26778915-8A617CE6-C9FA-4D52-B710-AA8086A37E23Q26778918-877FDA7B-9D31-438D-8DFE-212D9919A824Q26778925-D9A32B50-EE08-4D4B-9337-A8811B21731FQ26795440-0D7E1CAD-6BEC-48E0-9A7C-BB911860DF7EQ26822946-A71BC474-BD4B-430C-892B-D88D3BCF1C6FQ26830642-6A7D2600-5FDE-4123-80C8-BB998ABCF683Q26851663-1DA6BB16-9581-4938-8FA0-52C4614E726EQ26859144-193CD08A-3479-406C-BE6B-5D5DCAECF173Q26866919-4F2F97BE-55AD-4ED0-ADCD-BB5BCD00EC67Q26998663-99C04927-BEF0-4309-B02F-8D249B07AD59Q27011759-B2CE7976-1FB9-4E76-8552-4A31D37678A8Q27014027-6F72EF91-D09E-4420-9087-2BA9F5D8E53DQ27027301-FD772C5A-A42C-4634-8DA0-4AF954FE925DQ28081347-831BD478-0830-4F8F-95B2-2D38573FD385Q28082380-F11CE797-B407-47C2-B5CB-4E3984317C8FQ28082493-C899D85F-7BC1-4524-B937-FF9D2CB0B58AQ28239461-ED07B23A-0BB2-4EA8-B4EB-93D611E30D6BQ28282665-DAB1AF88-FB6F-4E88-8FC6-880116640E1AQ28285049-3D5CE615-689D-49EA-8619-E2A837190611Q28307595-F13703C7-D16E-46EB-8219-E15F47D8E8DBQ28397133-B11481F7-C26A-412A-8CCB-637B0D75B8E6Q30421612-FCC97ED8-10CB-4899-BD60-C136627ADAA8Q30450879-24798656-2AD0-4C90-82AF-04D72799E31DQ30870223-8FC7C710-630E-41E8-866D-CA620CA4B8C7Q31011291-6BB49A22-F504-4EF2-B5B1-F0967255765DQ31038202-A5EBD640-7CB9-4C24-B4F7-486414B789DCQ33420803-C973E493-ECAB-407F-A887-7BE8E189B2DEQ33563471-0DB42B9C-7961-44A4-8B46-8EBF72D56DD2Q33579369-746CB4DC-8B01-44FE-9F1D-DE197038A6F1Q33579375-2D4D3A31-471D-4578-BD0E-4C889CA4F672Q33579381-415A788A-A87F-423E-BEB8-DBBE0013285AQ33579388-BF762663-34B7-4136-8A7F-50655B61F989
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Future Medicine
@nl
wissenschaftliche Fachzeitschrift
@de
name
Biomarkers in Medicine
@en
Biomarkers in Medicine
@es
Biomarkers in Medicine
@it
Biomarkers in Medicine
@nl
type
label
Biomarkers in Medicine
@en
Biomarkers in Medicine
@es
Biomarkers in Medicine
@it
Biomarkers in Medicine
@nl
prefLabel
Biomarkers in Medicine
@en
Biomarkers in Medicine
@es
Biomarkers in Medicine
@it
Biomarkers in Medicine
@nl
P243
P3181
P1055
P1058
P1156
11300153402
P1159
P123
P1250
P1277
P1476
Biomarkers in Medicine
@en
P236
P243
P3181
P407
P571
2007-01-01T00:00:00Z